Moleculin Announces Additional Positive Interim Results in First Cohort of Phase 1/2 Clinical Studies of Annamycin in Acute Myeloid Leukemia in Europe
Stock Information for Moleculin Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.